Ryan J. Osgood

781 total citations
13 papers, 591 citations indexed

About

Ryan J. Osgood is a scholar working on Cell Biology, Molecular Biology and Oncology. According to data from OpenAlex, Ryan J. Osgood has authored 13 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cell Biology, 9 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Ryan J. Osgood's work include Proteoglycans and glycosaminoglycans research (10 papers), Fibroblast Growth Factor Research (8 papers) and Glycosylation and Glycoproteins Research (3 papers). Ryan J. Osgood is often cited by papers focused on Proteoglycans and glycosaminoglycans research (10 papers), Fibroblast Growth Factor Research (8 papers) and Glycosylation and Glycoproteins Research (3 papers). Ryan J. Osgood collaborates with scholars based in United States. Ryan J. Osgood's co-authors include Curtis B. Thompson, G. J. Frost, H. Michael Shepard, Ping Jiang, Xiaoming Li, Robert Connor, Barry J. Sugarman, Salam Kadhim, Louis H. Bookbinder and Zhongdong Huang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Ryan J. Osgood

12 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ryan J. Osgood United States	6	291	251	209	91	90	13	591
Allison P. Drain United States	5	311 1.1×	205 0.8×	198 0.9×	127 1.4×	135 1.5×	5	624
Christiana Polydorou Cyprus	9	328 1.1×	231 0.9×	176 0.8×	100 1.1×	293 3.3×	12	753
Itshak Golan Israel	7	173 0.6×	463 1.8×	270 1.3×	93 1.0×	48 0.5×	11	735
Junsong Chen China	14	270 0.9×	393 1.6×	126 0.6×	234 2.6×	68 0.8×	23	689
Sirisha Peddibhotla United States	11	300 1.0×	359 1.4×	106 0.5×	138 1.5×	124 1.4×	13	666
Sabrina Kellouche France	13	145 0.5×	231 0.9×	85 0.4×	69 0.8×	109 1.2×	28	549
Deepraj Ghosh United States	11	151 0.5×	189 0.8×	131 0.6×	90 1.0×	117 1.3×	19	501
Lorena Alba‐Castellón Spain	16	245 0.8×	426 1.7×	67 0.3×	90 1.0×	55 0.6×	30	703
Bingyan Wu United States	10	407 1.4×	346 1.4×	102 0.5×	81 0.9×	131 1.5×	26	982
Joost A.P. Rens Netherlands	12	148 0.5×	266 1.1×	61 0.3×	91 1.0×	197 2.2×	15	596

Countries citing papers authored by Ryan J. Osgood

Since Specialization

Citations

This map shows the geographic impact of Ryan J. Osgood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan J. Osgood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan J. Osgood more than expected).

Fields of papers citing papers by Ryan J. Osgood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan J. Osgood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan J. Osgood. The network helps show where Ryan J. Osgood may publish in the future.

Co-authorship network of co-authors of Ryan J. Osgood

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan J. Osgood. A scholar is included among the top collaborators of Ryan J. Osgood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan J. Osgood. Ryan J. Osgood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Parikh, Aparna R., E. Gabriela Chiorean, Chloé E. Atreya, et al.. (2024). Updated results from ERAS-007 plus encorafenib and cetuximab (EC) in patients (pts) with EC-naïve metastatic BRAF V600E colorectal cancer (CRC) in the phase 1b/2 HERKULES-3 study.. Journal of Clinical Oncology. 42(16_suppl). 3517–3517. 1 indexed citations

Abdelfattah, Eman, et al.. (2022). Classification of Movie Success: A Comparison of Two Movie Datasets. 8. 654–658. 2 indexed citations

Li, Xiaoming, H. Michael Shepard, Chun‐Mei Zhao, et al.. (2018). Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression. Clinical Cancer Research. 24(19). 4798–4807. 69 indexed citations

Osgood, Ryan J., et al.. (2018). PO-298 Pegylated recombinant human hyaluronidase PH20 (PEGPH20) increases tumour uptake and efficacy of cetuximab in a human pancreatic cancer xenograft model. ESMO Open. 3. A344–A344.

DuFort, Christopher C., Kathleen E. DelGiorno, Markus A. Carlson, et al.. (2016). Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase. Biophysical Journal. 110(9). 2106–2119. 128 indexed citations

Osgood, Ryan J., Yanling Chen, Li Zhu, et al.. (2015). Abstract B86: Pegylated recombinant human hyaluronidase PH20 (PEGPH20) enhances nab-paclitaxel plus gemcitabine efficacy in human pancreatic cancer xenografts. Cancer Research. 75(13_Supplement). B86–B86. 3 indexed citations

Kultti, Anne, Chun‐Mei Zhao, Netai C. Singha, et al.. (2014). Accumulation of Extracellular Hyaluronan by Hyaluronan Synthase 3 Promotes Tumor Growth and Modulates the Pancreatic Cancer Microenvironment. BioMed Research International. 2014. 1–15. 93 indexed citations

Kultti, Anne, Chun‐Mei Zhao, Ryan J. Osgood, et al.. (2014). Abstract 4844: Extracellular hyaluronan accumulation by hyaluronan synthase 3 promotes pancreatic cancer growth and modulates tumor microenvironment via epithelial-mesenchymal transition. Cancer Research. 74(19_Supplement). 4844–4844. 1 indexed citations

Jiang, Ping, Xiaoming Li, Curtis B. Thompson, et al.. (2012). Effective targeting of the tumor microenvironment for cancer therapy.. PubMed. 32(4). 1203–12. 49 indexed citations

10.

Osgood, Ryan J., et al.. (2012). Abstract 5635: Pegylated recombinant human hyaluronidase PH20 (PEGPH20) enhances Nab-Paclitaxel efficacy in BxPC-3 human pancreatic cancer xenografts. Cancer Research. 72(8_Supplement). 5635–5635. 6 indexed citations

11.

Jiang, Ping, Ryan J. Osgood, G. J. Frost, et al.. (2011). Abstract 2501: PEGylated human recombinant hyaluronidase (PEGPH20) enhances radiotherapy in hyaluronan-rich solid tumors. Cancer Research. 71(8_Supplement). 2501–2501. 3 indexed citations

12.

Thompson, Curtis B., H. Michael Shepard, P M O'Connor, et al.. (2010). Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models. Molecular Cancer Therapeutics. 9(11). 3052–3064. 235 indexed citations

13.

Kadhim, Salam, Ping Jiang, Ryan J. Osgood, et al.. (2010). Abstract 5392: Synergistic anti-tumor effects of pegylated recombinant human hyaluronidase (PEGPH20) with Gemcitabine in subcutaneous pancreatic cancer xenograft models. Cancer Research. 70(8_Supplement). 5392–5392. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact